APA (7th ed.) Citation

T, P., A, S., H, A., TM, L., & RV, O. (2020). Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approach. Diabetes, obesity & metabolism, 22(6), 969. https://doi.org/10.1111/dom.13985

Chicago Style (17th ed.) Citation

T, Papathanasiou, Strathe A, Agersø H, Lund TM, and Overgaard RV. "Impact of Dose-escalation Schemes and Drug Discontinuation on Weight Loss Outcomes with Liraglutide 3.0 mg: A Model-based Approach." Diabetes, Obesity & Metabolism 22, no. 6 (2020): 969. https://doi.org/10.1111/dom.13985.

MLA (9th ed.) Citation

T, Papathanasiou, et al. "Impact of Dose-escalation Schemes and Drug Discontinuation on Weight Loss Outcomes with Liraglutide 3.0 mg: A Model-based Approach." Diabetes, Obesity & Metabolism, vol. 22, no. 6, 2020, p. 969, https://doi.org/10.1111/dom.13985.